See more : Tapaco Public Company Limited (TAPAC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Halma plc (HLMAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Halma plc, a leading company in the Conglomerates industry within the Industrials sector.
You may be interested
- Doosan Enerbility Co., Ltd. (034020.KS) Income Statement Analysis – Financial Results
- Qatar First Bank L.L.C (Public) (QFBQ.QA) Income Statement Analysis – Financial Results
- Insimbi Industrial Holdings Limited (ISB.JO) Income Statement Analysis – Financial Results
- Guangdong Meiyan Jixiang Hydropower Co.,Ltd. (600868.SS) Income Statement Analysis – Financial Results
- Mirriad Advertising plc (MIRI.L) Income Statement Analysis – Financial Results
Halma plc (HLMAF)
About Halma plc
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.03B | 1.85B | 1.53B | 1.32B | 1.34B | 1.21B | 1.08B | 961.66M | 807.81M | 726.13M | 676.51M | 619.21M | 579.88M | 518.43M | 459.12M | 455.93M | 395.06M | 351.12M | 310.77M | 268.72M | 292.64M | 267.29M | 267.60M | 268.32M | 233.49M | 217.76M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost of Revenue | 1.03B | 974.90M | 801.00M | 704.60M | 707.10M | 644.80M | 540.67M | 482.82M | 408.97M | 342.87M | 321.99M | 297.70M | 285.01M | 345.84M | 310.53M | 313.84M | 266.58M | 236.58M | 207.44M | 208.06M | 205.12M | 187.01M | 189.02M | 187.97M | 163.50M | 152.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.00B | 877.90M | 724.30M | 613.60M | 631.30M | 566.10M | 535.54M | 478.84M | 398.83M | 383.26M | 354.52M | 321.51M | 294.88M | 172.59M | 148.59M | 142.09M | 128.48M | 114.54M | 103.33M | 60.66M | 87.52M | 80.29M | 78.57M | 80.35M | 69.99M | 65.63M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Gross Profit Ratio | 49.35% | 47.38% | 47.49% | 46.55% | 47.17% | 46.75% | 49.76% | 49.79% | 49.37% | 52.78% | 52.40% | 51.92% | 50.85% | 33.29% | 32.36% | 31.16% | 32.52% | 32.62% | 33.25% | 22.57% | 29.91% | 30.04% | 29.36% | 29.94% | 29.98% | 30.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 71.20M | 58.60M | 39.50M | 42.60M | 41.10M | 37.65M | 29.12M | 24.07M | 35.43M | 32.31M | 30.36M | 22.71M | 20.95M | 18.30M | 19.06M | 14.84M | 11.42M | 10.95M | 11.76M | 11.24M | 9.62M | 8.21M | 7.99M | 6.75M | 6.42M | 6.03M | 5.62M | 4.57M | 4.29M | 3.68M | 3.16M | 2.78M | 2.25M | 1.94M | 1.27M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.40M | 404.40M | 316.70M | 267.90M | 270.10M | 231.50M | 222.60M | 189.58M | 154.08M | 131.54M | 108.12M | 113.17M | 101.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 220.70M | 210.10M | 168.00M | 144.60M | 162.00M | 149.70M | 162.90M | 153.66M | 124.91M | 114.66M | 102.83M | 91.04M | 83.88M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 6.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 636.10M | 485.20M | 380.90M | 321.80M | 343.10M | 306.70M | 306.73M | 277.25M | 225.99M | 246.20M | 210.95M | 204.21M | 184.97M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 36.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.55M | -2.01M | -1.42M | -1.88M | -470.00K | 0.00 | 0.00 | -2.00M | -759.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.14M | 14.08M | 11.41M | 8.92M | 6.39M | 5.22M |
| Operating Expenses | 636.10M | 556.40M | 439.50M | 361.30M | 385.70M | 347.80M | 344.38M | 306.37M | 250.06M | 246.20M | 210.95M | 204.21M | 184.97M | 73.54M | 64.77M | 66.31M | 59.58M | 50.88M | 44.69M | 11.67M | 27.83M | 34.41M | 30.51M | 30.56M | 18.79M | 24.79M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost & Expenses | 1.67B | 1.53B | 1.24B | 1.07B | 1.09B | 992.60M | 885.05M | 789.19M | 659.03M | 589.07M | 532.94M | 501.91M | 469.97M | 419.38M | 375.30M | 380.15M | 326.16M | 287.45M | 252.13M | 219.73M | 232.95M | 221.41M | 219.53M | 218.53M | 182.29M | 176.92M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Interest Income | 3.10M | 700.00K | 200.00K | 800.00K | 600.00K | 400.00K | 255.00K | 211.00K | 217.00K | 134.00K | 252.00K | 195.00K | 9.74M | 317.00K | 189.00K | 643.00K | 721.00K | 1.04M | 1.03M | 5.66M | 995.00K | 1.22M | 820.00K | 708.00K | 1.09M | 1.62M | 1.00M | 845.00K | 1.09M | 874.00K | 719.00K | 1.36M | 1.06M | 1.10M | 929.00K | 222.00K | 319.00K | 213.00K | 247.00K |
| Interest Expense | 29.60M | 18.30M | 8.70M | 10.80M | 11.70M | 9.00M | 8.15M | 8.14M | 4.71M | 4.58M | 4.74M | 4.06M | 11.23M | 1.25M | 3.05M | 4.06M | 2.87M | 2.86M | 2.85M | 6.72M | 763.00K | 812.00K | 583.00K | 713.00K | 754.00K | 573.00K | 420.00K | 496.00K | 583.00K | 480.00K | 607.00K | 791.00K | 939.00K | 988.00K | 871.00K | 271.00K | 158.00K | 139.00K | 190.00K |
| Depreciation & Amortization | 105.60M | 101.50M | 88.60M | 90.30M | 84.70M | 66.20M | 62.31M | 57.65M | 44.90M | 40.68M | 36.31M | 31.90M | 27.67M | 21.73M | 21.23M | 20.34M | 15.88M | 13.13M | 11.34M | 9.32M | 7.88M | 7.55M | 7.37M | 7.02M | 6.25M | 5.75M | 5.33M | 4.99M | 4.40M | 4.01M | 3.53M | 2.96M | 2.51M | 2.23M | 1.80M | 1.44M | 1.13M | 935.00K | 756.00K |
| EBITDA | 475.50M | 410.60M | 373.40M | 342.60M | 320.60M | 282.30M | 243.20M | 224.04M | 187.39M | 178.87M | 179.73M | 148.41M | 150.87M | 121.27M | 105.36M | 97.19M | 85.58M | 78.15M | 70.83M | 63.99M | 59.04M | 51.64M | 53.91M | 55.50M | 50.77M | 47.87M | 47.97M | 42.57M | 38.60M | 33.72M | 29.21M | 24.64M | 17.67M | 16.47M | 16.81M | 13.07M | 10.37M | 7.54M | 6.22M |
| EBITDA Ratio | 23.38% | 22.83% | 24.48% | 25.99% | 24.68% | 23.49% | 23.55% | 23.93% | 23.98% | 24.43% | 26.58% | 23.97% | 25.35% | 23.40% | 22.95% | 21.24% | 21.66% | 22.17% | 22.85% | 23.81% | 20.17% | 20.47% | 21.02% | 21.44% | 21.74% | 22.14% | 22.44% | 21.40% | 22.28% | 21.99% | 21.70% | 21.30% | 20.33% | 20.12% | 21.52% | 21.39% | 20.40% | 20.45% | 19.98% |
| Operating Income | 367.70M | 321.50M | 284.80M | 252.30M | 245.60M | 218.30M | 191.16M | 172.47M | 148.78M | 137.06M | 143.57M | 117.30M | 109.91M | 99.45M | 84.30M | 76.21M | 70.17M | 63.98M | 58.46M | 49.02M | 46.21M | 42.80M | 45.72M | 47.77M | 42.14M | 40.50M | 41.81M | 36.73M | 33.11M | 28.84M | 24.96M | 20.33M | 15.50M | 14.24M | 15.01M | 11.63M | 9.24M | 6.60M | 5.47M |
| Operating Income Ratio | 18.08% | 17.35% | 18.67% | 19.14% | 18.35% | 18.03% | 17.76% | 17.93% | 18.42% | 18.88% | 21.22% | 18.94% | 18.95% | 19.18% | 18.36% | 16.71% | 17.76% | 18.22% | 18.81% | 18.24% | 15.79% | 16.01% | 17.09% | 17.80% | 18.05% | 18.60% | 19.56% | 18.35% | 19.07% | 18.76% | 18.45% | 17.50% | 16.39% | 17.40% | 19.22% | 19.04% | 18.18% | 17.91% | 17.55% |
| Total Other Income/Expenses | -27.40M | -30.00M | 25.60M | 600.00K | -16.00M | -11.10M | -15.30M | -9.37M | -11.82M | -3.45M | -4.89M | 2.12M | 2.06M | -1.16M | -2.92M | -3.42M | -2.14M | -1.83M | -1.82M | -1.05M | -9.30M | 474.00K | 237.00K | -5.00K | -7.44M | 1.05M | -5.18M | 349.00K | 509.00K | 394.00K | 112.00K | 565.00K | -1.28M | -988.00K | -871.00K | -271.00K | -158.00K | -139.00K | -190.00K |
| Income Before Tax | 340.30M | 291.50M | 304.50M | 252.90M | 224.20M | 206.80M | 172.26M | 157.78M | 136.45M | 133.61M | 138.68M | 120.14M | 111.97M | 98.29M | 81.37M | 72.79M | 68.02M | 62.15M | 56.64M | 47.96M | 36.92M | 43.27M | 45.96M | 47.76M | 34.70M | 41.55M | 36.63M | 37.08M | 33.62M | 29.23M | 25.08M | 20.89M | 14.22M | 13.26M | 14.14M | 11.36M | 9.08M | 6.46M | 5.28M |
| Income Before Tax Ratio | 16.73% | 15.73% | 19.96% | 19.19% | 16.75% | 17.08% | 16.01% | 16.41% | 16.89% | 18.40% | 20.50% | 19.40% | 19.31% | 18.96% | 17.72% | 15.96% | 17.22% | 17.70% | 18.23% | 17.85% | 12.61% | 16.19% | 17.17% | 17.80% | 14.86% | 19.08% | 17.13% | 18.53% | 19.36% | 19.02% | 18.53% | 17.99% | 15.04% | 16.19% | 18.10% | 18.60% | 17.87% | 17.54% | 16.94% |
| Income Tax Expense | 71.50M | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M | 17.72M | 28.01M | 27.45M | 29.61M | 32.35M | 26.53M | 25.26M | 25.86M | 20.94M | 20.21M | 19.69M | 18.45M | 17.03M | 14.47M | 14.59M | 14.91M | 14.80M | 15.64M | 12.69M | 12.96M | 11.85M | 11.97M | 10.69M | 9.42M | 8.29M | 6.47M | 4.55M | 4.09M | 4.56M | 3.73M | 3.24M | 2.28M | 1.93M |
| Net Income | 268.80M | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M | 154.20M | 129.69M | 108.84M | 104.00M | 106.33M | 93.61M | 86.71M | 72.43M | 60.44M | 52.58M | 50.28M | 44.01M | 40.88M | 34.55M | 22.32M | 28.36M | 31.16M | 32.12M | 22.01M | 28.59M | 24.78M | 25.10M | 22.93M | 19.81M | 16.79M | 14.40M | 9.67M | 8.08M | 10.43M | 7.93M | 5.84M | 3.69M | 3.33M |
| Net Income Ratio | 13.21% | 12.66% | 16.02% | 15.43% | 13.78% | 14.02% | 14.33% | 13.49% | 13.47% | 14.32% | 15.72% | 15.12% | 14.95% | 13.97% | 13.16% | 11.53% | 12.73% | 12.53% | 13.15% | 12.86% | 7.63% | 10.61% | 11.64% | 11.97% | 9.43% | 13.13% | 11.59% | 12.54% | 13.20% | 12.89% | 12.41% | 12.40% | 10.23% | 9.87% | 13.35% | 12.97% | 11.50% | 10.00% | 10.68% |
| EPS | 0.71 | 0.62 | 0.65 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.71 | 0.62 | 0.64 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 377.30M | 378.00M | 378.70M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.33M | 377.81M | 377.60M | 376.93M | 376.61M | 375.49M | 373.83M | 372.77M | 371.22M | 369.05M | 368.18M | 366.24M | 365.41M | 363.10M | 360.65M | 361.34M | 360.97M | 359.99M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
| Weighted Avg Shares Out (Dil) | 378.70M | 379.10M | 379.40M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.48M | 378.04M | 378.01M | 377.47M | 377.37M | 376.51M | 374.89M | 374.60M | 374.04M | 370.44M | 368.70M | 366.24M | 365.92M | 364.84M | 361.10M | 362.20M | 362.26M | 361.43M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
Halma plc (HLMAF) Q3 2024 Earnings Call Transcript
Halma plc (OTCPK:HLMAF) Q3 2024 Earnings Conference Call November 21, 2024 3:30 AM ET Company Participants Marc Ronchetti - Group Chief Executive Steve Gunning - CFO Conference Call Participants Andre Kukhnin - UBS Jonathan Hurn - Barclays Bank Max Yates...
Halma soars as half-year revenue tops £1bn, dividend hiked
Halma PLC (LSE:HLMA) shares jumped almost 10% on Thursday after the safety equipment firm hiked its dividend on record first-half results. Revenue jumped 13% to £1.07 billion in the six months to September, aiding a 17% increase in adjusted pre-tax profit to £222.5 million,...
JD Sports, Royal Mail, Close Bros, Halma feature on packed Thursday
A packed Thursday will see JD Sport, Close Brothers, IDS and Halma among a string of companies reporting.
Halma strengthens healthcare arm with French surgical tools buy
Halma strengthens healthcare arm with €50 million French buy Halma PLC (LSE:HLMA)has continued its purchase-led growth model with the acquisition of Paris-based surgical tools maker Lamidey Noury Medical for €50 million cash. Founded in 1947, Lamidey Noury devices are...
Halma tipped to report another period of solid growth
Halma PLC's (LSE:HLMA) flat share price over the past six months suggests another steady performance is on teh cards from the FTSE 100-listed, acquisition-driven engineer in next week; 's half-year numbers. “Halma's expected to keep things ticking over in next...
Halma's first-half results as ‘solid as ever' says Stifel
Halma PLC (LSE:HLMA)'s first-half trading update shows the safety products manufacturer is as “solid as ever” despite the negative impacts of currency headwinds, Stifel analysts today stated. FTSE 100-listed Halma cautioned that negative effects of a strong pound sterling will...
Halma outlook weighed down by resilient pound sterling
Safety products maker Halma PLC (LSE:HLMA) has cautioned that a strong pound sterling is a persistent headwind for the FTSE 100-listed group. “The appreciation of sterling is having a negative currency translation effect on the group's results; we expect this...
Halma has been quiet but a 21-year growth record speaks for itself
Halma PLC (LSE:HLMA), the safety products conglomerate, is due to provide a second-quarter update on Thursday 26 September, following a good report for its previous fiscal year – although that was back in June. Progress in its latest year included 10%...
Is Halma Worth The Hype? Analyzing Its 2024 Earnings And Premium Stock Valuation
Halma reported strong results for fiscal 2024, despite a challenging macroeconomic environment. In this update, I discuss Halma's latest results, highlight some aspects underlying the company's long-term success, and provide an updated valuation. Halma stock, which is virtually always expensive,...
Halma plc (HLMAF) Q4 2024 Earnings Call Transcript
Halma plc (OTCPK:HLMAF) Q4 2024 Earnings Conference Call July 13, 2023 3:30 AM ET Company Participants Marc Ronchetti - Group Chief Executive Steve Gunning - CFO Conference Call Participants Jonathan Hurn - Barclays Rory Smith - UBS Max Yates -...
Source: https://incomestatements.info
Category: Stock Reports